The effects on lower oesophageal sphincter tone of intravenous ranitidine 150 mg followed by atropine 0.6 mg were studied in six healthy volunteers. Ranitidine increased the mean lower oesophageal sphincter pressure by 21.2 cm H 2 0 (p <0.01). Subsequent injection of atropine lowered the lower oesophageal sphincter pressure but not significantly, mean sphincter pressure remaining 14.2 cm H20 above control. Barrier pressure to reflux (lower oesophageal sphincter pressure minus gastric pressure) increased significantly after intravenous ranitidine injection, and although it fell after intravenous atropine it was still above control levels. The results of this study suggest that ranitidine increases lower oesophageal sphincter tone. When it is given prior to atropine injection within 20 minutes before induction of anaesthesia it counteracts the deleterious effect of the latter on sphincter tone and barrier pressure to reflux.
Regurgitation and subsequent pulmonary aspiration of acid gastric content remain major causes of morbidity and mortality in both surgical and anaesthetic practice. 1 This risk has been associated with gastric fluid pH of both >2.5 2 and >3.5. 3 Ranitidine, a new H2 antagonist, has been introduced and is said to be several times more potent on a molar basis than cimetidine in inhibiting human gastric secretion. 4 While cimetidine has no effect on the human lower oesophageal sphincter (LOS)5 ranitidine has been claimed to increase LOS tone in humans. 6 A drug that will increase both LOS tone and gastric pH should be of great value in anaesthetic practice since it may reduce the incidence of aspiration pneumonitis. Atropine has a detrimental relaxant effect on the LOS, 7 and this can be countered by prior administration of metoclopramide. 8 The purpose of this study was to examine the effects of ranitidine on LOS in humans, and to ascertain if ranitidine given prior to atropine would counter the latter's LOS relaxant properties.
PATIENTS AND METHODS
Six healthy volunteers, all of whom gave informed consent, underwent oesophageal manometric studies. The study was approved by the Ethics and Standards Subcommittee of the Faculty of Medicine, University of Natal. Any previous history of upper gastrointestinal surgery or disease precluded entry to the study. The equipment and manometric methods have been previously described. Control measurements of intraluminal pressures in the stomach, lower oesophageal sphincter and oesophagus were measured after the subject had fasted for at least 10 hours. The volunteers then received ranitidine 150 mg intravenously and gastric, LOS and oesophageal pressures were measured five minutes later.
Atropine 0.6 mg was then injected intravenously and pressures were measured again five minutes later. The interval of five minutes was chosen to allow the effects of the drug on the sphincter tone to be manifest. The difference between the lower oesophageal sphincter and gastric pressures, termed the barrier pressure, was calculated. All pressures are expressed in centimetres of H20 above atmospheric pressure. Statistical comparisons were made using a Student t-test for paired data. A p value of <0.05 was considered as significant.
RESULTS
The average age of the subjects studied was 29.2 years (SO 9.1) and the mean body mass was 64.5 kg (SO 8.3). The mean basal pressures recorded in cm H20 were gastric 20.2 (SO 2.9), lower oesophageal sphincter 53.3 (SO 9.1) and oesophageal 2.1 (SO 1.6) ( Table 1 ). The mean barrier pressure was 33.1 (SO 7.4). Ranitidine injection significantly increased lower oesophageal sphincter tone (mean lower oesophageal sphincter pressure (cm H20) -74.5 SO 18.9) and barrier pressure to reflux (mean 52.2, SO 14.2). Following the administration of atropine, LOS and barrier pressures decreased, but not significantly, the mean sphincter pressure being maintained at 14.2 cm H20 above the control level.
DISCUSSION
Aspiration of gastric fluid into the lungs results from several factors, the most important being incompetence of the lower oesophageal sphincter. This sphincter is a specialised structure physiologically different from the rest of the oesophagus. 9 • 1O Reflux is defined as the retrograde flow of gastric content into the oesophagus, and the amount of reflux occurring depends upon the competence of the LOS. Haddad has shown that gastric reflux into (he oesophagus occurs when the barrier pressure is below 13 cm H20.11
Atropine has been shown to reduce LOS tone and bethanecol (a synthetic choline derivative) to increase it. The incidence of gastrooesophageal reflux is increased by atropine and significantly reduced by bethanecol administration. 7 The detrimental effect of atropine on LOS tone has been confirmed in both non-pregnant I2 . 13 and pregnant subjects. 14 The rationale underlying the use of atropine before anaesthesia for caesarean section has been discussed. 14 We are reluctant to advise against its use, especially in view of a recent report on the confidential enquiry into maternal mortality from England and Wales in which two women were deemed to have died from the vagal effects of suxamethonium because atropine was excluded from the preanaesthetic sequence. 15 The mechanism of action of ranitidine on LOS is not understood, while the action of atropine is most likely due to an antimuscarinic-anticholinergic effect at the post-ganglionic myoneural junction in the sphincter wall. 8 The dose and timing of administration of ranitidine and atropine used in this study was based on other recent studies of these agents and their action on lower oesophageal sphincter. 6 Of importance is the fact that these results were obtained between five and twenty minutes after drug injection. Ranitidine appeared to be free of undesirable side-effects in conscious adults.
Ranitidine is a H2 antagonist and increases gastric pH and raises LOS tone. These properties would recommend its use prior to induction of anaesthesia in patients at risk of developing gastro-oesophageal reflux.
